Nicotinamide modulates energy utilization and improves functional recovery from ischemia in the in vitro rabbit retina

Annals of the New York Academy of Sciences

Volumn 1053, Issue , 2005, Pages 258-268

  Tam, Diamond ^a   Tam, Majestic ^b   Maynard, Kenneth I ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d SANOFI   (France)

Author keywords

Hypoxia; Neuronal energy metabolism; Neuroprotection; Niacin; Nicotinamide (NAm); Stroke

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; LACTIC ACID; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINIC ACID;

ACTION POTENTIAL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENERGY METABOLISM; EYE BLOOD FLOW; GLUCOSE UTILIZATION; HYPOXIA; LIGHT; NERVE CELL; NEUROPROTECTION; NONHUMAN; RABBIT; RETINA; RETINA ISCHEMIA; STROKE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 29744448111     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1344.023     Document Type: Conference Paper

References (26)

1. SIESJO, B.K. 1992. Pathophysiology and treatment of focal cerebral ischemia. Part I: pathophysiology. J. Neurosurg. 77: 169-184.
2. MERGENTHALER, P., U. DIRNAGL & A. MEISEL. 2004. Pathophysiology of stroke: lessons from animal models. Metab. Brain Dis. 19: 151-167.
3. AMES, A., III, K.I. MAYNARD & S. KAPLAN. 1995. Protection against CNS ischemia by temporary interruption of function-related processes of neurons. J. Cereb. Blood Flow Metab. 15: 433-439.
4. MAYNARD, K.I., A. QUIÑONES & C.S. OGILVY. 1998. Magnesium plus mexiletine inhibit energy usage and protect retinas against ischemia. NeuroReport 9: 4141-4144.
5. MAYNARD, K.I., A. QUIÑONES-HINOJOSA & J. MALEK. 1999. Neuroprotection against ischemia by metabolic inhibition revisited: a comparison of hypothermia, a pharmacologic cocktail, and magnesium plus mexiletine. Ann. N.Y. Acad. Sci. 890: 240-254.
6. BEAL, M.F., D.R. HENSHAW, B.G. JENKINS et al. 1994. Co-enzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann. Neurol. 36: 882-888.
7. YANG, J., L.K. KLAIDMAN, A. NALBANDIAN et al. 2002. The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats. Neurosci. Lett. 333: 91-94.
8. +, as a PARP inhibitor, and by partial restoration of mitochondrial function. Pharmacology 69: 150-157.
9. MAYNARD, K.I., D. CHEN, P.M. ARANGO et al. 1996. Nitro-l-arginine worsens and l-arginine improves functional recovery when added during ischemia in the in vitro rabbit retina. NeuroReport 8: 81-85.
10. MAYNARD, K.I., P.M. ARANGO, D. CHEN et al. 1998. Acetylsalicylate administered during simulated ischemia impairs the recovery of neuronal function in the in vitro rabbit retina. Neurosci. Lett. 249: 159-162.
11. QUIÑONES-HINOJOSA, A., A. AMES III, J.Y. MALEK et al. 1999. An in vitro rabbit retina model to study electrophysiologic and metabolic function during and following ischemia. J. Neurosci. Methods 90: 107-115.
12. ZAGER, E.L. & A. AMES III. 1988. Reduction of cellular energy requirements: screening for agents that may protect against CNS ischemia. J. Neurosurg. 69: 568-579.
13. WALLIS, R.A., K.L. PANIZZON, D. HENRY et al. 1993. Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation. NeuroReport 5: 245-248.
14. LIN, S.H., A. VINCENT, T. SHAW et al. 2000. Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J. Cereb. Blood Flow Metab. 20: 1380-1391.
15. SONEE, M., J.R. MARTENS, M.R. EVERS et al. 2003. The effects of tertiary butylhydroperoxide and nicotinamide on human cortical neurons. Neurotoxicology 24: 443-448.
16. SHEN, C-C., H-M. HUANG, H-C. OU et al. 2004. Protective effect of nicotinamide on neuronal cells under oxygen and glucose deprivation and hypoxia/reoxygenation. J. Biomed. Sci. 11: 472-481.
17. + levels in ischemic core and penumbra. Neurochem. Res. 28: 1227-1234.
18. + and attenuation of lactacidemia during nicotinamide treatment of a patient with MELAS syndrome. Life Sci. 58: 691-699.
19. KURODA, S., K.I. KATSURA, R. TSUCHIDATE et al. 1996. Secondary bioenergetic failure after transient focal ischaemia is due to mitochondrial injury. Acta Physiol. Scand. 156: 149-150.
20. SIESJO, B.K., E. ELMER, S. JANELIDZE et al. 1999. Role and mechanisms of secondary mitochondrial failure. Acta Neurochir. Suppl. (Wien) 73: 7-13.
21. LUST, W.D., C. TAYLOR, S. PUNDIK et al. 2002. Ischemic cell death: dynamics of delayed secondary energy failure during reperfusion following focal ischemia. Metab. Brain Dis. 17: 113-121.
22. KLAIDMAN, L.K., S.K. MUKHERJEE & J.D. ADAMS, JR. 2001. Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim. Biophys. Acta 1525: 136-148.
23. VIRAG, L. & C. SZABO. 2001. Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB J. 15: 99-107.
24. MAYNARD, K.I. 2002. Natural neuroprotectants after stroke. Sci. Med. Sept/Oct: 258-267.
25. MACLEOD, M.R., T. O'COLLINS, D.W. HOWELLS et al. 2004. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35: 1203-1208.
26. + precursor and nutrient nicotinamide. Front. Biosci. 9: 2500-2520.